News

The Group 3 subtype of medulloblastoma has the worst prognosis of all the subtypes, but new research is pointing to a potential therapy.

An Ewing sarcoma researcher at MUSC is one of three scientists nationwide to receive a career development award from the Rally Foundation.

Dr. Charles P. Darby Jr. was an exceptional visionary, leader and advocate for pediatric care in South Carolina.

The parents of millions of teens don't intend to vaccinate them against HPV, a virus that can cause six types of cancer.

Alex's Lemonade Stand awarded Dr. Jezabel Rodriguez Blanco a grant to research ways to prevent medulloblastoma relapse, a cancerous brain tumor in kids.

A newly approved drug to prevent neuroblastoma relapse is a huge win for patients and their families, says Jacqueline Kraveka, D.O.

New treatment approach for babies born dependent on opioids gets them healthy and home faster.

MUSC initiative aims to increase human papillomavirus vaccination rates in underserved communities.

Jezabel R. Blanco is determined to find better treatments for children with medulloblastoma.

MUSC researchers created a model to find treatment options for a type of brain bleed in premature babies.